Coordinated induction of cyclooxygenase-2/ prostaglandin E2 and hepatocyte growth factor by apoptotic cells prevents lung fibrosis

Journal of Leukocyte Biology

Volumn 94, Issue 5, 2013, Pages 1037-1049

  Yoon, Young So ^a   Lee, Ye Ji ^a   Choi, Ji Yeon ^a   Cho, Min Sun ^a   Kang, Jihee Lee ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Alveolar macrophages; Bleomycin mice; Fibrosis; Pulmonary; TGF

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; BLEOMYCIN; CASPASE 3; CASPASE 9; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HYDROXYPROLINE; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ALVEOLAR MACROPHAGES; BLEOMYCIN; MICE; PULMONARY FIBROSIS; TGF-Β;

ANIMALS; APOPTOSIS; BLEOMYCIN; CYCLOOXYGENASE 2; DINOPROSTONE; HEPATOCYTE GROWTH FACTOR; INDOLES; MALE; MICE; MICE, INBRED C57BL; NITROBENZENES; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION; SULFONAMIDES; SULFONES; XANTHONES;

EID: 84887001008     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0513255     Document Type: Article

References (31)

1. Fadok, V. A., Bratton, D. I., Konowal, A., Freed, P. W., Westcott, J. Y., Henson, P. M. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/ paracrine mechanisms involving TGF-, PGE2, and PAF. J. Clin. Invest. 101, 890-898.
2. Huynh, M. L., Fadok, V. A., Henson, P. M. (2002) Phosphatidylserinedependent ingestion of apoptotic cells promotes TGF1 secretion and the resolution of inflammation. J. Clin. Invest. 109, 41-50.
3. Huynh, M. L., Malcolm, K. C., Kotaru, C., Tilstra, J. A., Westcott, J. Y., Fadok, V. A., Wenzel, S. E. (2005) Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. Am. J. Respir. Crit. Care Med. 172, 972-979.
4. Freire-de-Lima, C. G., Xiao, Y. Q., Gardai, S. J, Bratton, D. L., Schiemann, W. P., Henson, P. M. (2006) Apoptotic cells, through transforming growth factor-, oordinately induced anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J. Biol. Chem. 281, 38376-38384.
5. Majai, G., Sarang, Z., Csomós, K., Zahuczky, G., Fésüs, L. (2007) PPAR÷dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur. J. Immunol. 37, 1343-1354.
6. Henson, P. M., Vandivier, R. W., Douglas, I. S. (2006) Cell death, remodeling, and repair in chronic obstructive pulmonary disease? Proc. Am. Thorac. Soc. 3, 713-717.
7. Bozyk, P. D., Moore, B. B. (2011) Prostaglandin E2 and the pathogenesis of pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 45, 445-452.
8. White, K. E., Ding, Q., Moore, B. B., Peters-Golden, M., Ware, L. B., Matthay, M. A., Olman, M. A. (2008) Prostaglandin E2 mediates IL-1related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors. J. Immunol. 180, 637-646.
9. Kolodsick, J. E., Peters-Golden, M., Larios, J., Toews, G. B., Thannickal, V. J., Moore, B. B. (2003) Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am. J. Respir. Cell Mol. Biol. 29, 537-544.
10. Wilborn, J., Crofford, L. J., Burdick, M. D., Kunkel, S. L., Strieter, R. M., Peters-Golden, M. (1995) Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J. Clin. Invest. 95, 1861-1868.
11. Bauman, K. A., Wettlaufer, S. H., Okunishi, K., Vannella, K. M., Stoolman, J. S., Huang, S. K., Courey, A. J., White, E. S., Hogaboam, C. M., Simon, R. H., Toews, G. B., Sisson, T. H., Moore, B. B., Peters-Golden, M. (2010) The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. J. Clin. Invest. 120, 1950-1960.
12. Hodges, R. J., Jenkins, R. G., Wheeler-Jones, C. P., Copeman, D. M., Bottoms, S. E., Bellingan, G. J., Nanthakumar, C. B., Laurent, G. J., Hart, S. L., Foster, M. L., McAnulty, R. J. (2001) Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am. J. Pathol. 165, 1663-1676.
13. Keerthisingam, C. B., Jenkins, R. G., Harrison, N. K., Hernandez-Rodriguez, N. A., Booth, H., Laurent, G. J., Hart, S. L., Foster, M. L., McAnulty, R. J. (2001) Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factorin human fibrotic lung fibroblasts and promotes bleomycin-induced fibrosis in mice. Am. J. Pathol. 158, 1411-1422.
14. Moore, B. B., Coffey, M. J., Christensen, P., Sitterding, S., Ngan, R., Wilke, C. A., McDonald, R., Phare, S. M., Peters-Golden, M., Paine III, R., Toews, G. B. (2000) GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J. Immunol. 165, 4032-4039.
15. Lee, Y. J., Moon, C., Lee, S. H., Park, H. J., Seoh, J. Y., Cho, M. S., Kang, J. L. (2012) Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction. Eur. Respir. J. 40, 424-435.
16. Rao, G. V., Tinkle, S., Weissman, D. N., Antonini, J. M., Kashon, M. L., Salmen, R., Battelli, L. A., Willard, P. A., Hoover, M. D., Hubbs, A. F. (2003) Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J. Toxicol. Environ. Health A 66, 441-1452.
17. Peters, T., Mann, T. S., Henry, P. J. (2010) Inhibitory influence of protease-activated receptor 2 and E-prostanoid receptor stimulants in lipopolysaccharide models of acute airway inflammation. J. Pharmacol. Exp. Ther. 335, 424-433.
18. Christensen, J. G., Schreck, R., Burrows, J., Kuruganti, P., Chan, E., Le, P., Chen, J., Wang, X., Ruslim, L., Blake, R., Lipson, K. E., Ramphal, J., Do, S., Cui, J. J., Cherrington, J. M., Mendel, D. B. (2003) A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res. 63, 7345-7355.
19. Richens, T. R., Linderman, D. J., Horstmann, S. A., Lambert, C., Xiao, Y. Q., Keith, R. L., Boé, D. M., Morimoto, K., Bowler, R. P., Day, B. J., Janssen, W. J., Henson, P. M., Vandivier, R. W. (2009) Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am. J. Respir. Crit. Care Med. 179, 1011-1021.
20. Torr, E. E., Gardner, D. H., Thomas, L., Goodall, D. M., Bielemeier, A., Willetts, R., Griffiths, H. R., Marshall, L. J., Devitt, A. (2011) Apoptotic cell-derived ICAM-3 promotes both macrophage chemoattraction to and tethering of apoptotic cells. Cell Death Differ. 19, 671-679.
21. Morimoto, K., Janssen, W. J., Fessler, M. B., McPhillips, K. A., Borges, V. M., Bowler, R. P., Xiao, Y. Q., Kench, J. A., Henson, P. M., Vandivier, R. W. (2006) Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J. Immunol. 176, 7657-7665.
22. Medeiros, A. I., Serezani, C. H., Lee, S. P., Peters-Golden, M. (2009) Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J. Exp. Med. 106, 61-68.
23. Quesnel, C., Marchand-Adam, S., Fabre, A., Marchal-Somme, J., Philip, I., Lasocki, S., Leçon, V., Crestani, B., Dehoux, M. (2008) Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L334-L343.
24. Siegfried, J. M., Gubish, C. T., Rothstein, M. E., Queiroz de Oliveira, P. E., Stabile, L. P. (2007) Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer. Mol. Pharmacol. 72, 769-779.
25. Matsumoto-Taniura, N., Matsumoto, K., Nakamura, T. (1999) Prosta glandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts. Br. J. Cancer 81, 194-202.
26. Zhang, A., Wang, M. H., Dong, Z., Yang, T. (2006) Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor. Am. J. Physiol. Renal Physiol. 291, F1323-F1331.
27. McAnulty, R. J., Hernandez-Rodriguez, N. A., Mutsaers, S. E., Coker, R. K., Laurent, G. J. (1997) Indomethacin suppresses the anti-proliferative effects of transforming growth factorisoforms on fibroblast cell cultures. Biochem. J. 321, 639-643.
28. Shen, W., Li, Y., Zhu, J., Schwendener, R., Huard, J. (2008) Interaction between macrophages, TGF1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury. J. Cell. Physiol. 214, 405-412.
29. Shukla, M. N., Rose, J. L., Ray, R., Lathrop, K. L., Ray, A., Ray, P. (2009) Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Am. J. Respir. Cell Mol. Biol. 40, 643-653.
30. Yang, J., Dai, C., Liu, Y. (2003) Hepatocyte growth factor suppresses re nal interstitial myofibroblast activation and intercepts Smad signal transduction. Am. J. Pathol. 163, 621-632.
31. Lekushi, K., Taniyama, Y., Azuma, J., Sanada, F., Kusunoki, H., Yokoi, T., Koibuchi, N., Okayama, K., Rakugi, H., Morishita, R. (2010) Hepatocyte growth factor attenuates renal fibrosis through TGF1 suppression by apoptosis of myofibroblasts. J. Hypertens. 28, 2454-2461.